Novel  High  Concentration  I.V. Caffeine Rapid Reversal  Agent

Address Limitations of Naloxone and Increase Available Treatment Options for OIRD

OYE medical lab

Clinical Development

Our Clinical Development Program holds the promise to save lives across a range of therapeutic areas from the OR to the ER to the field, where Emergency Medical Personnel bring treatments directly to patients. Our novel formulation helps patients at their most vulnerable. It also speeds up transitions in care, providing benefits to patients in all those environments.

A chart illustrating three phases of anesthesia recovery, comparing RGA and OIRD methods. The phases are divided into three sections: Phase I, Phase II, and Phase III. The RGA process progresses through these phases steadily, while OIRD completes the phases earlier, especially in Phase III.

Phase